O. Outteryck

发表

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

G. Plant, P. Vermersch, P. Calabresi, 2015, Multiple sclerosis.

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

Alexander Klistorner, Bernhard Hemmer, Pablo Villoslada, 2017, The Lancet Neurology.

Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss

P. Vermersch, J. Pruvo, É. Drumez, 2016, Multiple sclerosis.

Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.

A. Luciani, P. Vermersch, A. Rahmouni, 2016, Radiology.

Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI.

O. Commowick, C. Barillot, A. Tucholka, 2020, Diagnostic and interventional imaging.

Longitudinal follow-up of vision in a neuromyelitis optica cohort

P. Vermersch, P. Labauge, J. de Seze, 2013, Multiple sclerosis.

Accuracy of Postcontrast 3D Turbo Spin-Echo MR Sequence for the Detection of Enhanced Inflammatory Lesions in Patients with Multiple Sclerosis

P. Vermersch, J. Pruvo, J. Hodel, 2014, American Journal of Neuroradiology.

Asymptomatic optic nerve lesions

P. Vermersch, J. Pruvo, Renaud Lopes, 2020, Neurology.

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration

R. Hohlfeld, E. Meinl, M. Spadaro, 2016, Journal of Neurology.

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study

L. Leocani, X. Montalban, F. Paul, 2019, Multiple sclerosis journal - experimental, translational and clinical.

Natalizumab in relapsing-remitting multiple sclerosis

O. Outteryck, 2016, Expert review of neurotherapeutics.

COVID-19 Neurologic Complication with CNS Vasculitis-Like Pattern

J. Pruvo, L. Hacein-Bey, J. Constans, 2020, American Journal of Neuroradiology.

Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome

P. Vermersch, J. Pruvo, Renaud Lopes, 2020, Neurology.

A New Monitoring Tool for Multiple Sclerosis

P. Vermersch, O. Outteryck, A. Petzold, 2010 .

Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice

P. Vermersch, F. Blanc, H. Zéphir, 2010, Journal of Neurology.

A Fully Automatic Method for Optic Radiation Tractography Applicable to Multiple Sclerosis Patients

J. Pruvo, Renaud Lopes, J. Dumont, 2020, Brain Topography.

Proinflammatory B-cell profile in the early phases of MS predicts an active disease

P. Vermersch, D. Launay, H. Zéphir, 2017, Neurology: Neuroimmunology & Neuroinflammation.

Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence

P. Vermersch, J. Pruvo, M. Benadjaoud, 2017, European Radiology.

Brain imaging determinants of functional prognosis after severe endocarditis: a multicenter observational study

B. Souweine, J. Reignier, R. Robert, 2022, Neurological Sciences.

Intrusive experiences in posttraumatic stress disorder: Treatment response induces changes in the directed functional connectivity of the anterior insula

P. Yger, R. Jardri, G. Vaiva, 2022, NeuroImage: Clinical.

Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD

S. Vukusic, J. Giovannelli, D. Laplaud, 2021, Neurology.

Neuromyelitis optica and pregnancy

P. Vermersch, S. Vukusic, D. Brassat, 2012, Neurology.

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study

F. Paul, R. Hohlfeld, E. Meinl, 2019, Journal of Neuroinflammation.

APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies

J. Schuman, L. Leocani, S. Saidha, 2021, Neurology.

Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype

F. Cassim, P. Hatron, O. Outteryck, 2017, Journal of Neurology.

Extensive myelitis associated with anti-NMDA receptor antibodies

P. Vermersch, J. Honnorat, G. Baille, 2013, BMC Neurology.

Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

P. Vermersch, J. Pruvo, V. Deramecourt, 2015, American Journal of Neuroradiology.

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

P. Vermersch, M. Giroud, M. Clanet, 2015, Brain : a journal of neurology.

Relation between retina, cognition and brain volumes in MS: a consequence of asymptomatic optic nerve lesions

Renaud Lopes, X. Leclerc, O. Outteryck, 2022, Journal of Neurology.

Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy

P. Vermersch, J. Pruvo, V. Deramecourt, 2018, Multiple sclerosis.

Punctate pattern

P. Vermersch, J. Pruvo, V. Deramecourt, 2016, Neurology.

A prospective observational post‐marketing study of natalizumab‐treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

P. Vermersch, M. Clanet, B. Brochet, 2014, European journal of neurology.

Longitudinal Retinal Changes in MOGAD

S. Saidha, P. Calabresi, C. Tilikete, 2022, Annals of neurology.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

The earlier, the smaller, the better for natalizumab-associated PML: In MRI vigilance veritas?

G. Moonen, P. Vermersch, C. Sindic, 2012, Neurology.

Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy

P. Vermersch, A. Duhamel, F. Blanc, 2012, Journal of Neurology.

JC-virus seroconversion in multiple sclerosis patients receiving natalizumab

P. Vermersch, J. Salleron, F. Blanc, 2014, Multiple sclerosis.

Low signals on t2(star) and swi sequences in patients with ms with progressive multifocal leukoencephalopathy reply

P. Vermersch, J. Pruvo, V. Deramecourt, 2016 .

REPLY:

P. Vermersch, J. Pruvo, V. Deramecourt, 2016, American Journal of Neuroradiology.

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis

P. Vermersch, H. Zéphir, N. Collongues, 2012, Journal of Neurology.

Switching for convenience from first-line injectable treatments to oral treatments in multiple sclerosis: Data from a retrospective cohort study.

P. Vermersch, J. Giovannelli, H. Zéphir, 2019, Multiple sclerosis and related disorders.

Optical Coherence Tomography - A New Monitoring Tool for Multiple Sclerosis?

P. Vermersch, O. Outteryck, A. Petzold, 2010 .

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study

A. Vighetto, A. Toosy, F. Sedel, 2018, CNS Drugs.

F. Pasquier, S. Bombois, V. Deramecourt, 2007, Revue neurologique.

Evaluation of efficacy and tolerability of first-line therapies in NMOSD

S. Vukusic, J. Giovannelli, D. Laplaud, 2020, Neurology.

Neuromyelitis optica in France

J Grimaud, G Castelnovo, J Pelletier, 2010, Neurology.

Optical coherence tomography: a window to the optic nerve in clinically isolated syndrome

Jérôme Hodel, Patrick Vermersch, Julien Labreuche, 2019, Brain : a journal of neurology.

Is neuromyelitis optica associated with human leukocyte antigen?

P. Vermersch, I. Fajardy, S. Vukusic, 2009, Multiple sclerosis.

Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study

P. Vermersch, J. Pruvo, M. Benadjaoud, 2014, European Radiology.

Characterization of alexithymia in clinically isolated syndrome.

H. Zéphir, O. Outteryck, S. Hennion, 2021, Revue neurologique.

Does Fatigue Complaint Reflect Memory Impairment in Multiple Sclerosis?

P. Vermersch, H. Zéphir, O. Outteryck, 2014, Multiple sclerosis international.

4H syndrome: a rare cause of leukodystrophy

P. Vermersch, D. Devos, O. Boespflug-Tanguy, 2010, Journal of Neurology.

Imaging spectrum of Bing–Neel syndrome: how can a radiologist recognise this rare neurological complication of Waldenström’s macroglobulinemia?

J. Dietemann, P. Vermersch, D. Galanaud, 2018, European Radiology.

Long-term follow-up of acute partial transverse myelitis.

P. Vermersch, D. Hannequin, S. Debette, 2012, Archives of neurology.

Relapsing demyelinating disease affecting both the central and peripheral nervous systems

P. Vermersch, P. Latour, T. Stojkovic, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion

P. Vermersch, J. Pruvo, J. Hodel, 2018, Multiple sclerosis.

Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study

Valeria Panebianco, Wolfgang Reith, Carlo Cosimo Quattrocchi, 2021, BMC Medical Imaging.

Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort

P. Vermersch, L. Kremer, F. Sellal, 2020, Multiple sclerosis.

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

Alexander Klistorner, Pablo Villoslada, Shiv Saidha, 2016, The Lancet Neurology.

Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life

André Thevenon, Arnaud Lacour, Vincent Tiffreau, 2015, Journal of Neurology.

Optic Nerve Lesion Length at the Acute Phase of Optic Neuritis Is Predictive of Retinal Neuronal Loss

J. Pruvo, É. Drumez, X. Leclerc, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability

D. Brassat, R. Bernard-Valnet, P. Clavelou, 2015, Journal of Neurology.

Relation between retina, cognition and brain volumes in MS: a consequence of asymptomatic optic nerve lesions

Renaud Lopes, X. Leclerc, O. Outteryck, 2022, Journal of Neurology.

Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients.

J. Dumont, X. Leclerc, R. Lopes, 2021, Revue neurologique.

Author Response: Asymptomatic Optic Nerve Lesions: An Underestimated Cause of Silent Retinal Atrophy in MS

X. Leclerc, O. Outteryck, 2020, Neurology.

A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis

Sabine Defoort-Dhellemmes, Patrick Vermersch, Olivier Outteryck, 2015, Multiple sclerosis.

Evaluation of health‐related quality of life, fatigue and depression in neuromyelitis optica

P. Vermersch, F. Blanc, J. de Seze, 2011, European journal of neurology.

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study

F. Paul, R. Hohlfeld, E. Meinl, 2019, Journal of Neuroinflammation.

OCT Findings in Neuromyelitis Optica Spectrum Disorders

P. Vermersch, O. Outteryck, 2016 .

Intrusive Experiences In Post-Traumatic Stress Disorder: Treatment Response Induces Changes In The Effective Connectivity of The Anterior Insula

R. Jardri, G. Vaiva, Renaud Lopes, 2020, bioRxiv.

Fluid-attenuated inversion recovery vascular hyperintensities are not visible using 3D CUBE FLAIR sequence

J. Pruvo, M. Rodallec, S. Gerber, 2013, European Radiology.

Pulse-Triggered DTI Sequence with Reduced FOV and Coronal Acquisition at 3T for the Assessment of the Cervical Spinal Cord in Patients with Myelitis

P. Vermersch, J. Pruvo, M. Rodallec, 2013, American Journal of Neuroradiology.

Continuous hemifacial myokymia as the revealing symptom of demyelinating disease of the CNS.

P. Vermersch, H. Zéphir, O. Outteryck, 2017, Multiple Sclerosis and Related Disorders.

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy

P. Vermersch, S. Vukusic, B. Brochet, 2016, Neurology.

Evaluation of risk management in a natalizumab home infusion procedure

J. Giovannelli, H. Zéphir, O. Outteryck, 2023, Revue neurologique.

Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss.

P. Vermersch, J. de Seze, H. Zéphir, 2009, Archives of neurology.

Methionine synthase deficiency: A rare cause of adult-onset leukoencephalopathy

P. Vermersch, V. Deramecourt, T. Stojkovic, 2012, Neurology.

Follow-Up MRI for Small Brain AVMs Treated by Radiosurgery: Is Gadolinium Really Necessary?

J. Pruvo, N. Reyns, O. Guillaud, 2020, American Journal of Neuroradiology.

[Myelitis as a differential diagnosis of spinal cord tumors].

P. Vermersch, H. Zéphir, O. Outteryck, 2017, Neuro-Chirurgie.

Giant cell arteritis-related cerebrovascular ischemic events: a French retrospective study of 271 patients, systematic review of the literature and meta-analysis

E. Hachulla, D. Launay, H. Hénon, 2023, Arthritis Research & Therapy.

Autoimmune cerebellar ataxia with glutamic acid decarboxylase 65 antibodies associated with central vestibular symptoms

P. Vermersch, H. Zéphir, O. Outteryck, 2017, Acta Neurologica Belgica.

[Cerebral vasculitis secondary to Varicella-Zoster virus infection].

I. Delalande, O. Outteryck, F. Mounier-Véhier, 2005, Revue neurologique.

Late-onset of Alpers-Huttenlocher syndrome: an unusual cause of refractory epilepsy and liver failure

P. Vermersch, H. Zéphir, O. Outteryck, 2017, Acta Neurologica Belgica.

Mixed connective tissue disease presenting as trigeminal neuropathy

P. Vermersch, D. Launay, O. Outteryck, 2014, Acta Neurologica Belgica.

Artificial intelligence extension of the OSCAR‐IB criteria

Thomas E. Wisnewski, Jerry L Prince, J. Schuman, 2021, Annals of clinical and translational neurology.

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

G. Plant, P. Vermersch, P. Calabresi, 2015, Multiple sclerosis.

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.

C. Louapre, S. Vukusic, C. Mékiès, 2019, Revue neurologique.

High-risk syndrome for neuromyelitis optica: a descriptive and comparative study

P. Vermersch, D. Brassat, M. Debouverie, 2011, Multiple sclerosis.

Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy

H. Zéphir, O. Outteryck, S. Rogeau, 2023, Neurotherapeutics.

Natalizumab in relapsing-remitting multiple sclerosis

O. Outteryck, 2016, Expert review of neurotherapeutics.

Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores

S. Saidha, P. Calabresi, J. Bellmann-Strobl, 2024, Neurology(R) neuroimmunology & neuroinflammation.

Periorbital ecchymoses are not pathognomonic of the light-chain type of amyloidosis.

P. Vermersch, T. Stojkovic, D. Launay, 2007, Acta dermato-venereologica.